Zinc is a trace element involved in insulin metabolism, including its production, storage, and release. Selenium is regarded as a vital micronutrient for humans. It participates in insulin signaling and control. Zinc and selenium may be possibly linked to insulin resistance; however, these relationships have not been well investigated. Therefore, we sought to examine the relationship between blood zinc and selenium levels and insulin resistance in apparently healthy individuals. This study used a cross-sectional design including 203 apparently healthy people. Measurements were taken to determine zinc and selenium serum levels, fasting insulin, fasting blood glucose, and glycosylated hemoglobin. Insulin resistance was measured by utilizing the Homeostatic Model Assessment (HOMA-IR). The prevalence of insulin resistance, as determined by HOMA-IR, was 26.11%. Patients with insulin resistance had higher age (59.96 ± 12.28 years), body mass index (26.66 ± 3.16 kg/m²), and waist-tohip ratio (0.93 ± 0.05) compared to those with insulin sensitivity (54.19 ± 9.88 years, 25.92 ± 2.4 kg/m², 0.91 ± 0.05), with statistically significant differences (p-values―0.013, 0.013, 0.029, respectively). Serum zinc levels were elevated in insulin-sensitive individuals (87.12 ± 6.87 mcg/mL) compared to those who were insulin-resistant (84.05 ± 8.29 mcg/mL), with a p-value of 0.036. HbA1c concentration and fasting insulin levels were elevated in the insulin-resistant group (4.95 ± 0.49, 15.78 ± 1.59) compared to the insulin-sensitive group (4.79 ± 0.38, 10.1 ± 2.34), with p-values of 0.033 and 0.003, respectively. In apparently healthy adults, there is an association between low serum zinc levels and insulin resistance. There is no association between selenium serum levels and insulin resistance.
References
1.
Nakamura A, Kido T, Seki Y, Suka M. Zinc deficiency affects insulin secretion and alters insulin-regulated metabolic signaling in rats. Journal of Trace Elements in Medicine and Biology. 2024;83:127375.
2.
Rajpathak S, Rimm E, Morris JS, Hu F. Toenail Selenium and Cardiovascular Disease in Men with Diabetes. Journal of the American College of Nutrition. 2005;24(4):250–6.
3.
Bleys J, Navas-Acien A, Guallar E. Serum Selenium and Diabetes in U.S. Adults. Diabetes Care. 2007;30(4):829–34.
4.
Fontenelle LC, Feitosa MM, Morais JBS, Severo JS, Freitas TEC de, Beserra JB, et al. The role of selenium in insulin resistance. Brazilian Journal of Pharmaceutical Sciences. 54(1).
5.
Cardoso BR, Braat S, Graham RM. Selenium Status Is Associated With Insulin Resistance Markers in Adults: Findings From the 2013 to 2018 National Health and Nutrition Examination Survey (NHANES). Frontiers in Nutrition. 8.
6.
Moon S, Chung HS, Yu JM, Yoo HJ, Park JH, Kim DS, et al. Association between serum selenium level and the prevalence of diabetes mellitus in U.S. population. Journal of Trace Elements in Medicine and Biology. 2019;52:83–8.
7.
Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. The Lancet. 2010;375(9733):2267–77.
8.
Goktepe E, Baltaci SB, Unal O, Unlukal N, Mogulkoc R, Baltaci AK. The relationship between beta cell activation and SLC30A8/ZnT8 levels of the endocrine pancreas and maternal zinc deficiency in rats. Journal of Trace Elements in Medicine and Biology. 2023;79:127217.
9.
Levine A, McClain C, Handwerger B, Brown D, Morley J. Tissue zinc status of genetically diabetic and streptozotocin-induced diabetic mice. The American Journal of Clinical Nutrition. 1983;37(3):382–6.
10.
Lann D, LeRoith D. Insulin Resistance as the Underlying Cause for the Metabolic Syndrome. Medical Clinics of North America. 2007;91(6):1063–77.
11.
Wiernsperger N. Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes & Metabolism. 2003;29(6):579–85.
12.
Ilouz R, Kaidanovich O, Gurwitz D, Eldar-Finkelman H. Inhibition of glycogen synthase kinase-3β by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochemical and Biophysical Research Communications. 2002;295(1):102–6.
13.
Tang X han, Shay NF. Zinc Has an Insulin-Like Effect on Glucose Transport Mediated by Phosphoinositol-3-Kinase and Akt in 3T3-L1 Fibroblasts and Adipocytes. The Journal of Nutrition. 2001;131(5):1414–20.
14.
Luo YY, Zhao J, Han XY, Zhou XH, Wu J, Ji LN. Relationship Between Serum Zinc Level and Microvascular Complications in Patients with Type 2 Diabetes. Chinese Medical Journal. 2015;128(24):3276–82.
15.
Fernández-Cao JC, Warthon-Medina M, Hall Moran V, Arija V, Doepking C, Lowe NM. Dietary zinc intake and whole blood zinc concentration in subjects with type 2 diabetes versus healthy subjects: A systematic review, meta-analysis and meta-regression. Journal of Trace Elements in Medicine and Biology. 2018;49:241–51.
16.
Fukunaka A, Fujitani Y. Role of Zinc Homeostasis in the Pathogenesis of Diabetes and Obesity. International Journal of Molecular Sciences. 19(2):476.
17.
Maret W. Zinc in Pancreatic Islet Biology, Insulin Sensitivity, and Diabetes. Preventive Nutrition and Food Science. 2017;22(1):1–8.
18.
Bjørklund G, Dadar M, Pivina L, Doşa MD, Semenova Y, Aaseth J. The Role of Zinc and Copper in Insulin Resistance and Diabetes Mellitus. Current Medicinal Chemistry. 2020;27(39):6643–57.
19.
Cruz KJC, de Oliveira ARS, Morais JBS, Severo JS, Mendes PMV, de Sousa Melo SR, et al. Zinc and Insulin Resistance: Biochemical and Molecular Aspects. Biological Trace Element Research. 2018;186(2):407–12.
20.
Ahn BI, Kim MJ, Koo HS, Seo N, Joo NS, Kim YS. Serum Zinc Concentration Is Inversely Associated with Insulin Resistance but Not Related with Metabolic Syndrome in Nondiabetic Korean Adults. Biological Trace Element Research. 2014;160(2):169–75.
21.
Islam MdR, Arslan I, Attia J, McEvoy M, McElduff P, Basher A, et al. Is Serum Zinc Level Associated with Prediabetes and Diabetes?: A Cross-Sectional Study from Bangladesh. PLoS ONE. 8(4):e61776.
22.
Khalid SH, Hashim ZH, Al-mayah QS, Al-matubsi H. Predictive value of lipid profile in predicting the resistance to insulin in apparently healthy adults. ACTA Pharmaceutica Sciencia. 2024;62(3):678.
23.
Al-Mayah Q, Ghani ZA, Qaddori H. Triglyceride/high-density lipoprotein ratio as a predictor for insulin resistance in a sample of healthy Iraqi adults. Journal of Medicine and Life. 16(5):668–74.
24.
Esteghamati A, Ashraf H, Esteghamati AR, Meysamie A, Khalilzadeh O, Nakhjavani M, et al. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: The implication of metabolic syndrome to detect insulin resistance. Diabetes Research and Clinical Practice. 2009;84(3):279–87.
25.
Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, et al. Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutrition & Metabolism. 2010;7(1):26.
26.
Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F, De Francisco A, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocrine Disorders. 2013;13(1).
27.
Steinbrenner H, Duntas LH, Rayman MP. The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities. Redox Biology. 2022;50:102236.
28.
Wongdokmai R, Shantavasinkul PC, Chanprasertyothin S, Panpunuan P, Matchariyakul D, Sritara P, et al. The Involvement of Selenium in Type 2 Diabetes Development Related to Obesity and Low Grade Inflammation. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. Volume 14:1669–80.
29.
Kieliszek M. Selenium–Fascinating Microelement, Properties and Sources in Food. Molecules. 24(7):1298.
30.
Slepchenko KG, Daniels NA, Guo A, Li YV. Autocrine effect of Zn2+ on the glucose-stimulated insulin secretion. Endocrine. 2015;50(1):110–22.
31.
Rungby J. Zinc, zinc transporters and diabetes. Diabetologia. 2010;53(8):1549–51.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
